Share Name Share Symbol Market Type Share ISIN Share Description
Sareum Holdings Plc LSE:SAR London Ordinary Share GB00B02RFS12 ORD 0.025P
  Price Change % Change Share Price Shares Traded Last Trade
  -0.015 -3.85% 0.375 5,109,154 14:25:00
Bid Price Offer Price High Price Low Price Open Price
0.37 0.38 0.39 0.375 0.39
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology -1.72 -0.05 12
Last Trade Time Trade Type Trade Size Trade Price Currency
16:27:06 O 400,000 0.3799 GBX

Sareum (SAR) Latest News

More Sareum News
Sareum Takeover Rumours

Sareum (SAR) Share Charts

1 Year Sareum Chart

1 Year Sareum Chart

1 Month Sareum Chart

1 Month Sareum Chart

Intraday Sareum Chart

Intraday Sareum Chart

Sareum (SAR) Discussions and Chat

Sareum Forums and Chat

Date Time Title Posts
19/7/201908:16Sareum 2015 3,119
22/8/201719:18Sareum 2016722
12/12/201612:19SAR Sareum Drug Discovery Co.15,853
26/4/201618:292012 Sareum Unleashed4,546
20/4/201609:23SAR news is on its way. fasten your seatbelts!172

Add a New Thread

Sareum (SAR) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Sareum trades in real-time

Sareum (SAR) Top Chat Posts

Sareum Daily Update: Sareum Holdings Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker SAR. The last closing price for Sareum was 0.39p.
Sareum Holdings Plc has a 4 week average price of 0.38p and a 12 week average price of 0.38p.
The 1 year high share price is 0.90p while the 1 year low share price is currently 0.38p.
There are currently 3,071,364,219 shares in issue and the average daily traded volume is 5,299,378 shares. The market capitalisation of Sareum Holdings Plc is £11,517,615.82.
cerrito: The current FX rate is doing nothing for the share price.
cerrito: I note yesterday's announcement has done little for the Sierra share price currently at 0.58c
yzf750: Not quite ..... SDC-1801 is further advanced and currently demonstrating excellent tolerability with doses up to 30 times the level that gave good responses in efficacy studies; an MTD has yet to be reached. At least I haven't seen this before. We just need the share price to catch up.....
cerrito: Does anyone understand what is happening to the Sierra share price if their recent news has been apparently so good?
fadec92: The chances of a milestone have just increased and shortened as said by Tim due to the trials being successful and an early route to registration through Anogenital Cancer! looks as if it has strong synergistic quality’s with PD-L1 Immuno-oncology for SCLC (Small Cell Lung Cancer) where it seams PD-L1 on its own dosnt work but pair it with both SRA737 and LDG and it regresses tumors 100% in 21days and a complete response (CR) with 80% cures at day 60, this is exactly the type of treatment that patents need, this will and is a blockbuster, who cares about the share price, market will have to catch up and it will!
cerrito: At least SAR share price up; at time of writing, SRA down at US1.04
robizm: Dont know how the share price will react Monday though.
cerrito: I have been AWOL this week so just now have had the chance to catch up with the Sierra quarterly statement and the 10-Q . More precisely I see that on Page 16 they discuss possible milestone payments and while they mention Gilead and Cama on SRA141, they are silent on our SRA 737. No change then from the equivalent commentary on page 87 of the 10-k as at December 31 2018. This would suggest to me that it is unlikely that we will get any milestones before the need to raise fresh equity after the summer break. This explains the current share price. My reading is that even though we now have a QCA compliant Board of Directors, we have seen no institutional buying-I have just been on the FT website to see their listing of sub 3 pc holders and there seem to be no new faces.
spacedust: Marten & Co values Sareum’s 27.5% economic interest in SRA737 at £20.3m and places an indicative value on its TYK2 assets of £8-16m, representing a modest upgrade from its previous position. This suggests an overall value for Sareum of £25-35m (0.87-1.14p/share), which offers up to 63% upside to the current share price
cerrito: Sierra have just announced quote Sierra Oncology Announces Late-Breaking Oral and Poster Presentations at AACR 2019 for SRA737 and SRA141 Preclinical Data unquote I look forward to Mrs A's insight if this will move the dial for the SAR price. I see that Sierra's share price has had a good last month going up from 1.34 to 1.82 but still way below the 52 week high of 3.70
Sareum share price data is direct from the London Stock Exchange
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190722 18:29:06